Search
for
Sort by
Research 181–210 of 1000+
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report
- The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata.
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- A review of Janus kinase inhibitor use in scarring alopecia
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Inhibidor janus kinasa como opción terapéutica en alopecia areata. Reporte de caso
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- JAK inhibitors and alopecia areata
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Alopecia universalis. Partial response to tofacitinib
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Tofacitinib for the treatment of alopecia areata in preadolescent children